Discover the Potential of Eltrekibart for Treating Hidradenitis Suppurativa

This study is a Phase 2b, double-blind, placebo-controlled trial evaluating Eltrekibart in adult participants with moderate to severe hidradenitis suppurativa.

Kentucky location for dermatology study by Equity Medical
Study Location
Kentucky
Office Address
1802 Rockingham Ave. Bowling Green, KY 42104
Office Phone
270-213-7777

Overview

Recruiting start date
  • 10/1/24
Duration
  • 16 Weeks
Study Drug

Eltrekibart

Delivery

Subcutaneous Injection

Sponsor

Eli Lilly and Company

Phase

2

Mechanism of Action

CXCR1 and CXCR2 ligands

Inclusion Criteria
  • Have a diagnosis of HS for at least 12 months.
  • Have HS lesions in at least 2 distinct anatomical regions. At least 1 of the lesions must be at least Hurley Stage II or III.
  • Have an (abscess plus inflammatory nodule) count of at least 5.
  • Agree to use topical antiseptics daily.
  • Had an inadequate response or intolerance to a 28-day course of oral antibiotics.
Exclusion Criteria
  • Have more than 20 draining fistulae.
  • Have had surgical treatment for HS in the last 4 weeks before randomization.
  • Have an active skin disease or condition that could interfere with the assessment of HS.
  • Have a current or recent acute, active infection.
  • Are immunocompromised.
  • Have a history of chronic alcohol abuse, IV drug abuse, or other illicit drug abuse within 1 year before screening.
Important Notes:

This study aims to find the appropriately safe and effective dose and dosing frequency for Eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.

Studies
Contact us to join a dermatology study clinical trial

Contact Us Today!

Whether it be eczema, dandruff, or psoriasis, being a part of our research is an impactful way to explore treatments and medications. Even if there isn’t a current study that’s a perfect fit for you, take the first step and sign up to learn more and be considered for future studies in New York and Kentucky. Click the button below to get started!